Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

BUY
$27.14 - $34.93 $354,204 - $455,871
13,051 New
13,051 $385,000
Q2 2023

Jul 27, 2023

BUY
$23.51 - $30.09 $280,685 - $359,244
11,939 New
11,939 $308,000

Others Institutions Holding MIRM

About Mirum Pharmaceuticals, Inc.


  • Ticker MIRM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,751,700
  • Market Cap $1.92B
  • Description
  • Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...
More about MIRM
Track This Portfolio

Track Genworth Financial Inc Portfolio

Follow Genworth Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Genworth Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Genworth Financial Inc with notifications on news.